Xencor, Inc. (XNCR)
24.72
+0.13
(+0.53%)
USD |
NASDAQ |
Sep 18, 16:00
24.72
0.00 (0.00%)
After-Hours: 20:00
Xencor Enterprise Value : 1.551B for Sept. 18, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 1.551B |
| September 17, 2026 | 1.541B |
| September 16, 2026 | 1.476B |
| September 15, 2026 | 1.479B |
| September 14, 2026 | 1.537B |
| September 11, 2026 | 1.528B |
| September 10, 2026 | 1.517B |
| September 09, 2026 | 1.567B |
| September 08, 2026 | 1.596B |
| September 04, 2026 | 1.692B |
| September 03, 2026 | 1.692B |
| September 02, 2026 | 1.713B |
| September 01, 2026 | 1.788B |
| August 31, 2026 | 1.740B |
| August 28, 2026 | 1.651B |
| August 27, 2026 | 1.860B |
| August 26, 2026 | 1.828B |
| August 25, 2026 | 1.891B |
| August 24, 2026 | 1.869B |
| August 21, 2026 | 1.780B |
| August 20, 2026 | 1.721B |
| August 19, 2026 | 1.759B |
| August 18, 2026 | 1.602B |
| August 17, 2026 | 1.432B |
| August 14, 2026 | 1.448B |
| Date | Value |
|---|---|
| August 13, 2026 | 1.422B |
| August 12, 2026 | 1.437B |
| August 11, 2026 | 1.356B |
| August 10, 2026 | 1.318B |
| August 07, 2026 | 1.260B |
| August 06, 2026 | 1.200B |
| August 05, 2026 | 1.188B |
| August 04, 2026 | 1.194B |
| August 03, 2026 | 1.156B |
| July 31, 2026 | 1.216B |
| July 30, 2026 | 1.311B |
| July 29, 2026 | 1.165B |
| July 28, 2026 | 1.198B |
| July 27, 2026 | 1.190B |
| July 24, 2026 | 1.159B |
| July 23, 2026 | 1.165B |
| July 22, 2026 | 1.164B |
| July 21, 2026 | 1.234B |
| July 20, 2026 | 1.112B |
| July 17, 2026 | 1.012B |
| July 16, 2026 | 824.87M |
| July 15, 2026 | 827.10M |
| July 14, 2026 | 824.87M |
| July 13, 2026 | 825.62M |
| July 10, 2026 | 891.77M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| UroGen Pharma Ltd. | 2.200B |
| MeiraGTx Holdings Plc | 1.217B |
| Regeneron Pharmaceuticals, Inc. | 75.86B |
| Ironwood Pharmaceuticals, Inc. | 1.038B |
| MacroGenics, Inc. | 288.44M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -21.73M |
| Revenue (Quarterly) | 51.22M |
| Total Expenses (Quarterly) | 72.95M |
| EPS Diluted (Quarterly) | -0.2864 |
| Gross Profit Margin (Quarterly) | 95.24% |
| Profit Margin (Quarterly) | -42.42% |
| Earnings Yield | -8.78% |
| Normalized Earnings Yield | -10.65 |